Assure Tech Hangzhou Co Ltd (688075) - Total Liabilities
Based on the latest financial reports, Assure Tech Hangzhou Co Ltd (688075) has total liabilities worth CN¥611.60 Million CNY (≈ $89.50 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Assure Tech Hangzhou Co Ltd - Total Liabilities Trend (2017–2025)
This chart illustrates how Assure Tech Hangzhou Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See Assure Tech Hangzhou Co Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Assure Tech Hangzhou Co Ltd Competitors by Total Liabilities
The table below lists competitors of Assure Tech Hangzhou Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Shanghai New World Co Ltd
SHG:600628
|
China | CN¥1.47 Billion |
|
Sunny Loan Top Co Ltd
SHG:600830
|
China | CN¥3.98 Billion |
|
Happiest Minds Technologies Limited
NSE:HAPPSTMNDS
|
India | Rs18.00 Billion |
|
SZZT Electronics Co Ltd
SHE:002197
|
China | CN¥4.21 Billion |
|
Vamos Locação de Caminhões Máquinas e Equipamentos S.A
SA:VAMO3
|
Brazil | R$19.84 Billion |
|
Log-In Logística Intermodal S.A
SA:LOGN3
|
Brazil | R$2.76 Billion |
|
Zenitron Corp
TW:3028
|
Taiwan | NT$15.51 Billion |
|
Ceepower Co Ltd
SHE:300062
|
China | CN¥1.18 Billion |
Liability Composition Analysis (2017–2025)
This chart breaks down Assure Tech Hangzhou Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Assure Tech Hangzhou Co Ltd.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 8.87 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.12 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.11 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Assure Tech Hangzhou Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Assure Tech Hangzhou Co Ltd (2017–2025)
The table below shows the annual total liabilities of Assure Tech Hangzhou Co Ltd from 2017 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥515.98 Million ≈ $75.50 Million |
-9.40% |
| 2024-12-31 | CN¥569.52 Million ≈ $83.34 Million |
-16.72% |
| 2023-12-31 | CN¥683.83 Million ≈ $100.07 Million |
-55.10% |
| 2022-12-31 | CN¥1.52 Billion ≈ $222.85 Million |
+125.97% |
| 2021-12-31 | CN¥673.95 Million ≈ $98.62 Million |
+133.02% |
| 2020-12-31 | CN¥289.22 Million ≈ $42.32 Million |
+418.82% |
| 2019-12-31 | CN¥55.75 Million ≈ $8.16 Million |
-34.05% |
| 2018-12-31 | CN¥84.53 Million ≈ $12.37 Million |
-11.94% |
| 2017-12-31 | CN¥95.99 Million ≈ $14.05 Million |
-- |
About Assure Tech Hangzhou Co Ltd
Assure Tech (Hangzhou) Co., Ltd. engages in the research and development, production, and sale of vitro diagnostic reagents, and instruments in China. It is also involved in POCT and plastic product manufacturing; online sales; pharmaceutical sales; and medical testing. In addition, the company offers drug of abuse, infectious disease, fertility, cardiac marker, tumor marker, allergen, and veteri… Read more